Company: BACC
Filing Date: 2025-06-02
Form Type: S-1/A
Source: 0001185185-25-000574
Chunk: 366

Company: Blue Acquisition Corp/Cayman
Filing Date: 2025-06-02
Form: S-1/A
Chunk 366
---
 registration rights. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company will grant the underwriters a 45-day
option from the date of the Proposed Public Offering to purchase an additional 2,625,000 units to cover over-allotments, if any.

The underwriters will be entitled to a cash underwriting
discount of 2.00% of the gross proceeds of the Proposed Public Offering, or $3,500,000 (or $4,025,000 if the underwriters’ over-allotment
is exercised in full), payable upon the closing of the Proposed Public Offering. Additionally, the underwriters will be entitled to a
deferred underwriting discount of 3.5% of the gross proceeds of the Proposed Public Offering, or $6,125,000 (or $7,043,750 if the overallotment
option is exercised in full) in the aggregate. The deferred commissions will be released to the underwriters only on completion of an
initial business combination. The deferred commissions will be payable as follows: (i) $0.20 per unit sold in this offering shall be
paid to the underwriter in cash, and (ii) $0.15 per unit sold in this offering shall be paid to the underwriters in cash based on the
funds remaining in the trust account after giving effect to public shares that are redeemed in connection with an initial business combination.

Representative Shares

The Company intends to issue to the underwriters
and/or their designees 175,000 ordinary shares (the “Representative Shares”) upon the consummation of the Proposed Public
Offering. The Company will account for the Representative Shares as a cost of the Proposed Public Offering, resulting in a charge directly
to share’s equity. The underwriters (and any of their designees to whom the Representative Shares are issued) will agree not to
transfer, assign or sell any such shares without the Company’s prior consent until the completion of a Business Combination. In
addition, the Representative Shares will be deemed to be underwriting compensation by the Financial Industry Regulatory Authority, Inc.
(“FINRA”) pursuant to FINRA Rule 5110 and will, accordingly, be subject to certain transfer restrictions or a period
of 180 days beginning on the date of commencement of sales of the Units in the Proposed Public Offering. Furthermore, the underwriters
will agree (and any of their designees to whom